Craft

Gubra

Revenue

KR2.6 B

FY, 2025

Gubra Summary

Company Summary

Overview
Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services. It specializes in peptide chemistry, in vivo pharmacology, 3D imaging, molecular pharmacology, stereology, bioinformatics, etc.
Type
Public
Status
Active
Founded
2008
HQ
Hørsholm, DK | view all locations
Website
https://www.gubra.dk
Cybersecurity rating
Sectors

Key People

  • Henrik Blou

    Henrik Blou, Chief Executive Officer

  • Niels Vrang

    Niels Vrang, Co-Founder, Chief Science Officer

  • Kristian Borbos

    Kristian Borbos, Chief Financial Officer

  • Trine Nygaard Hamann

    Trine Nygaard Hamann, Chief Business Officer

Operating MetricsView all

Customers

101
7.4%

FY, 2022

Products in Development

14

FY, 2022

LocationsView all

1 location detected

  • Hørsholm HQ

    Denmark

    Hørsholm Kongevej 11B

Gubra Financials

Summary Financials

Revenue (FY, 2025)
kr2.6B
Gross profit (FY, 2025)
kr2.6B
Net income (FY, 2025)
kr1.7B
Cash (FY, 2025)
kr32.2M
EBIT (FY, 2025)
kr2.2B

Footer menu